Colon News and Research

RSS

Abdominal chemotherapy boosts survival in ovarian cancer patients

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone

10 Jan 2006

Statins do not appear to reduce the incidence of cancer

The cholesterol-lowering medications called statins do not appear to reduce the incidence of cancer or cancer deaths, according to a meta-analysis of previous studies in the January 4 issue of JAMA: The Journal of the American Medical Association.

6 Jan 2006

Promising new therapy for ulcerative colitis

For people with the chronic disease ulcerative colitis, life can be limited to few social functions and trips away from home.

6 Jan 2006

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.

6 Jan 2006

Caspase 8 gene halts spread of aggressive childhood cancer

A team of cancer researchers has shown that a gene commonly lost during neuroblastoma tumor formation, one of the most aggressive cancers in babies and children, is in fact a "metastasis suppressor" gene.

6 Jan 2006

Daily dose of Vitamin D cuts cancer risk

According to cancer prevention specialists, taking vitamin D3 daily appears to lower the risk of cancer by up to as much 50 percent.

28 Dec 2005

Micro-gyroscopes could detect, monitor and provide therapy guidance on cancer

A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.

22 Dec 2005

Eating chicken may reduce colon cancer risk

A recent study in The American Journal of Gastroenterology revealed that patterns in diet may effect the development of colorectal adenomas, or precancerous polyps of the colon.

19 Dec 2005

High fibre diet gives little protection against bowel cancer

The once accepted doctrine that a high fibre diet prevents cancer has been challenged by new dietary research.

14 Dec 2005

Chemotherapy is a beneficial treatment women and elderly

Although all eligible patients with stage III colon cancer should be offered adjuvant chemotherapy treatment because it improves survival, up to one-third are not, and many of these excluded patients are women and the elderly, say researchers who looked at data from more than 85,000 patients.

7 Dec 2005

Liver plays crucial role in iron metabolism

A new study in the December Cell Metabolism reveals an unexpected connection between a tumor suppressor gene in the liver and the normally careful control over the amount of iron absorbed from the diet.

7 Dec 2005

Cancer cell resistance to chemotherapy drugs - mechanism discovered

Technion-Israel Institute of Technology researchers have discovered new mechanisms developed by cancer cells to become resistant to various chemotherapy drugs.

6 Dec 2005

Findings may help in development of new anti-inflammatory compounds

Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma, multiple sclerosis, lung and colon cancers and Alzheimer's disease.

2 Dec 2005

Study finds AKT blocks cancer cell motility

PIn investigating the molecular mechanisms of cancer cell motility - the unique property that enables cancer to spread from its primary origin to other parts of the body - researchers have uncovered a surprising role for the AKT/PKB (protein kinase B) enzyme

26 Nov 2005

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Introgen Therapeutics, Inc. today reported the publication of preclinical data demonstrating that INGN 241 works synergistically with celecoxib (Celebrex) marketed by Pfizer to inhibit the growth and increase apoptosis (cell death) of breast cancer cells.

8 Nov 2005

Doctor facing manslaughter charges in Australia sparks calls for overhaul of U.S. regulations

An Indian-born, American-trained surgeon who is facing possible manslaughter charges in Australia, and nicknamed "Dr Death" has sparked calls for an overhaul of health regulations and a review of malpractice suits in his U.S. home state of Oregon.

8 Nov 2005

BRAF gene mutations predict sensitivity to a new class of drug

A team of researchers led by scientists at Memorial Sloan-Kettering Cancer Center have discovered that a new class of drugs -- now in early stage clinical trials -- work best in patients with mutations in the BRAF gene.

7 Nov 2005

Expert highlights public health problem posed by colorectal cancer

Colorectal cancer is a significant public health problem for which differing treatment regimes hold different benefits in associated efficacy, safety and tolerability, according to study findings showcased at the 13th European Cancer Conference (ECCO).

3 Nov 2005

New targeted cancer drug delivery system

Prostate, breast and other cancer patients may be offered a new, stauncher targeted drug delivery system to treat their diseases in the next decade.

3 Nov 2005

Study examines cancer risks after cancer diagnosis in family

After a person is diagnosed with cancer, increased surveillance among their family members may result in the earlier detection of asymptomatic familial cancers.

3 Nov 2005